Larson Financial Group’s Filana Therapeutics FLNA Stock Holding History

Larson Financial Group’s Portfolio FLNA Stock Details FLNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$9	Hold	10	–	–	﹤0.01%	3835
2026 Q2	$12	Hold	10	–	–	﹤0.01%	3730
2026 Q1	$17	Hold	10	–	–	﹤0.01%	3587
2025 Q4	$20	Buy	+10	New	+$32	﹤0.01%	3410
2024 Q4	–	Sell	-100	Closed	-$2.94K	–	2886
2024 Q3	$2.94K	Hold	100	–	–	﹤0.01%	1781
2024 Q2	$1.24K	Hold	100	–	–	﹤0.01%	1668
2024 Q1	$2.03K	Hold	100	–	–	﹤0.01%	1359
2023 Q4	$2.25K	Hold	100	–	–	﹤0.01%	1352
2023 Q3	$1.66K	Hold	100	–	–	﹤0.01%	1392
2023 Q2	$2.45K	Hold	100	–	–	﹤0.01%	1239
2023 Q1	$2.41K	Buy	100 +61	+156%	+$1.69K	﹤0.01%	1218
2022 Q4	$1.15K	Hold	39	–	–	﹤0.01%	1269
2022 Q3	$2K	Buy	+39	New	+$1.05K	﹤0.01%	1139
2021 Q4	–	Sell	-42	Closed	-$3K	–	1161
2021 Q3	$3K	Buy	+42	New	+$3.5K	﹤0.01%	752

Other funds holding FLNA

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Simplex Trading Chicago, Illinois $184B AUM 51.71% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

MGO One Seven Beachwood, Ohio $6.08B AUM 21.44% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Apollon Wealth Management Mount Pleasant, South Carolina $8.72B AUM 23.07% 1-Year Est. Return

Activest Wealth Management Aventure, Florida $540M AUM 34.92% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

SEP

Signature Equity Partners Columbus, Ohio $287M AUM 21.26% 1-Year Est. Return

Physician Wealth Advisors Midvale, Utah $869M AUM 17.6% 1-Year Est. Return

Larson Financial Group's FLNA Position: Q3 2026 in Review

Larson Financial Group held its Filana Therapeutics (FLNA) position steady in Q3 2026 at 10 shares worth $9. The position accounts for ﹤0.01% of the portfolio, ranked #3835.

Larson Financial Group first reported a position in FLNA in Q3 2021 and has held it in 14 quarters since. The position peaked at $3K in Q3 2021. 24 funds tracked by Wall St. Rank hold FLNA as of Q3 2026.

Larson Financial Group held 10 shares of Filana Therapeutics worth $9 as of Q3 2026.
Larson Financial Group left its Filana Therapeutics share count unchanged in Q3 2026.
Filana Therapeutics made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #3835 holding.
Larson Financial Group first reported a position in Filana Therapeutics in Q3 2021 and has held it in 14 quarters since.
Larson Financial Group's Filana Therapeutics position peaked at $3K in Q3 2021.
24 funds tracked by Wall St. Rank held Filana Therapeutics as of Q3 2026.

Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.